Table 1.

Baseline clinical characteristics of the total participants, individuals who did or did not develop diabetes, and individuals treated or untreated for diabetes.

 Total (n = 23,622)Non-diabetes (n = 21,897)Diabetes (n = 1,725)P value Untreated diabetes (n = 1,193)Treated diabetes (n = 532)P value #
Age (years)38.8 ± 11.538.4 ± 11.644.2 ± 8.8<0.000145.4 ± 8.541.5 ± 9.0<0.0001
 <20 years322 (1.36)315 (1.44)7 (0.41)3 (0.25)4 (0.75)
 20–29 years6,940 (29.38)6,790 (31.01)150 (8.70)89 (7.46)61 (11.47)
 30–39 years5,515 (23.35)5,169 (23.61)346 (20.06)187 (15.67)159 (29.89)
 40–49 years5,419 (22.94)4,701 (21.47)718 (41.62)505 (42.33)213 (40.04)
 50–59 years5,403 (22.87)4,899 (22.37)504 (29.22)409 (34.28)95 (17.86)
 ≥60 years23 (0.10)23 (0.11)0 (0.00)0 (0.00)0 (0.00)
Male sex21,492 (91.0)19,783 (90.4)1,708 (99.0)<0.00011,179 (98.8)529 (99.4)0.24
BMI (kg/m2)23.2 ± 3.422.9 ± 3.225.9 ± 4.2<0.000125.2 ± 3.927.4 ± 4.4<0.0001
Systolic BP (mmHg)124 ± 14124 ± 14131 ± 15<0.0001131 ± 15130 ± 130.66
Diastolic BP (mmHg)78 ± 1077 ± 1083 ± 10<0.000183 ± 1183 ± 100.16
HbA1c (%) (mmol/mol) 5.4 ± 0.3 (36 ± 4)5.4 ± 0.3 (35 ± 3)5.8 ± 0.4 (40 ± 5)<0.00015.7 ± 0.4 (39 ± 4)5.9 ± 0.6 (41 ± 6)<0.0001
Fasting plasma glucose (mmol/mol) 5.37 ± 0.525.32 ± 0.456.02 ± 0.78<0.00015.97 ± 0.726.11 ± 0.910.002
Current smoker §8,894 (38.4)8,034 (37.4)860 (51.0)<0.0001589 (50.6)271 (51.9)0.62
 Total (n = 23,622)Non-diabetes (n = 21,897)Diabetes (n = 1,725)P value Untreated diabetes (n = 1,193)Treated diabetes (n = 532)P value #
Age (years)38.8 ± 11.538.4 ± 11.644.2 ± 8.8<0.000145.4 ± 8.541.5 ± 9.0<0.0001
 <20 years322 (1.36)315 (1.44)7 (0.41)3 (0.25)4 (0.75)
 20–29 years6,940 (29.38)6,790 (31.01)150 (8.70)89 (7.46)61 (11.47)
 30–39 years5,515 (23.35)5,169 (23.61)346 (20.06)187 (15.67)159 (29.89)
 40–49 years5,419 (22.94)4,701 (21.47)718 (41.62)505 (42.33)213 (40.04)
 50–59 years5,403 (22.87)4,899 (22.37)504 (29.22)409 (34.28)95 (17.86)
 ≥60 years23 (0.10)23 (0.11)0 (0.00)0 (0.00)0 (0.00)
Male sex21,492 (91.0)19,783 (90.4)1,708 (99.0)<0.00011,179 (98.8)529 (99.4)0.24
BMI (kg/m2)23.2 ± 3.422.9 ± 3.225.9 ± 4.2<0.000125.2 ± 3.927.4 ± 4.4<0.0001
Systolic BP (mmHg)124 ± 14124 ± 14131 ± 15<0.0001131 ± 15130 ± 130.66
Diastolic BP (mmHg)78 ± 1077 ± 1083 ± 10<0.000183 ± 1183 ± 100.16
HbA1c (%) (mmol/mol) 5.4 ± 0.3 (36 ± 4)5.4 ± 0.3 (35 ± 3)5.8 ± 0.4 (40 ± 5)<0.00015.7 ± 0.4 (39 ± 4)5.9 ± 0.6 (41 ± 6)<0.0001
Fasting plasma glucose (mmol/mol) 5.37 ± 0.525.32 ± 0.456.02 ± 0.78<0.00015.97 ± 0.726.11 ± 0.910.002
Current smoker §8,894 (38.4)8,034 (37.4)860 (51.0)<0.0001589 (50.6)271 (51.9)0.62

Values are n (%) or the mean ± standard deviation.

Participants whose HbA1c values were measured: total (n = 21,995), non-diabetes (n = 20,270), diabetes (n = 1,725), untreated diabetes (n = 1,193), and treated diabetes (n = 532).

Participants whose fasting plasma glucose values were measured: total (n = 21,109), non-diabetes (n = 19,456), diabetes (n = 1,653), untreated diabetes (n = 1,147), and treated diabetes (n = 506).

§Participants whose current smoking status was confirmed by a questionnaire: total (n = 23,146), nondiabetes (n = 21,460), diabetes (n = 1,686), untreated diabetes (n = 1,164), and treated diabetes (n = 522).

Non-diabetes vs. diabetes.

#Untreated diabetes vs. treated diabetes.

BP, blood pressure; HbA1c, glycated hemoglobin.

Table 1.

Baseline clinical characteristics of the total participants, individuals who did or did not develop diabetes, and individuals treated or untreated for diabetes.

 Total (n = 23,622)Non-diabetes (n = 21,897)Diabetes (n = 1,725)P value Untreated diabetes (n = 1,193)Treated diabetes (n = 532)P value #
Age (years)38.8 ± 11.538.4 ± 11.644.2 ± 8.8<0.000145.4 ± 8.541.5 ± 9.0<0.0001
 <20 years322 (1.36)315 (1.44)7 (0.41)3 (0.25)4 (0.75)
 20–29 years6,940 (29.38)6,790 (31.01)150 (8.70)89 (7.46)61 (11.47)
 30–39 years5,515 (23.35)5,169 (23.61)346 (20.06)187 (15.67)159 (29.89)
 40–49 years5,419 (22.94)4,701 (21.47)718 (41.62)505 (42.33)213 (40.04)
 50–59 years5,403 (22.87)4,899 (22.37)504 (29.22)409 (34.28)95 (17.86)
 ≥60 years23 (0.10)23 (0.11)0 (0.00)0 (0.00)0 (0.00)
Male sex21,492 (91.0)19,783 (90.4)1,708 (99.0)<0.00011,179 (98.8)529 (99.4)0.24
BMI (kg/m2)23.2 ± 3.422.9 ± 3.225.9 ± 4.2<0.000125.2 ± 3.927.4 ± 4.4<0.0001
Systolic BP (mmHg)124 ± 14124 ± 14131 ± 15<0.0001131 ± 15130 ± 130.66
Diastolic BP (mmHg)78 ± 1077 ± 1083 ± 10<0.000183 ± 1183 ± 100.16
HbA1c (%) (mmol/mol) 5.4 ± 0.3 (36 ± 4)5.4 ± 0.3 (35 ± 3)5.8 ± 0.4 (40 ± 5)<0.00015.7 ± 0.4 (39 ± 4)5.9 ± 0.6 (41 ± 6)<0.0001
Fasting plasma glucose (mmol/mol) 5.37 ± 0.525.32 ± 0.456.02 ± 0.78<0.00015.97 ± 0.726.11 ± 0.910.002
Current smoker §8,894 (38.4)8,034 (37.4)860 (51.0)<0.0001589 (50.6)271 (51.9)0.62
 Total (n = 23,622)Non-diabetes (n = 21,897)Diabetes (n = 1,725)P value Untreated diabetes (n = 1,193)Treated diabetes (n = 532)P value #
Age (years)38.8 ± 11.538.4 ± 11.644.2 ± 8.8<0.000145.4 ± 8.541.5 ± 9.0<0.0001
 <20 years322 (1.36)315 (1.44)7 (0.41)3 (0.25)4 (0.75)
 20–29 years6,940 (29.38)6,790 (31.01)150 (8.70)89 (7.46)61 (11.47)
 30–39 years5,515 (23.35)5,169 (23.61)346 (20.06)187 (15.67)159 (29.89)
 40–49 years5,419 (22.94)4,701 (21.47)718 (41.62)505 (42.33)213 (40.04)
 50–59 years5,403 (22.87)4,899 (22.37)504 (29.22)409 (34.28)95 (17.86)
 ≥60 years23 (0.10)23 (0.11)0 (0.00)0 (0.00)0 (0.00)
Male sex21,492 (91.0)19,783 (90.4)1,708 (99.0)<0.00011,179 (98.8)529 (99.4)0.24
BMI (kg/m2)23.2 ± 3.422.9 ± 3.225.9 ± 4.2<0.000125.2 ± 3.927.4 ± 4.4<0.0001
Systolic BP (mmHg)124 ± 14124 ± 14131 ± 15<0.0001131 ± 15130 ± 130.66
Diastolic BP (mmHg)78 ± 1077 ± 1083 ± 10<0.000183 ± 1183 ± 100.16
HbA1c (%) (mmol/mol) 5.4 ± 0.3 (36 ± 4)5.4 ± 0.3 (35 ± 3)5.8 ± 0.4 (40 ± 5)<0.00015.7 ± 0.4 (39 ± 4)5.9 ± 0.6 (41 ± 6)<0.0001
Fasting plasma glucose (mmol/mol) 5.37 ± 0.525.32 ± 0.456.02 ± 0.78<0.00015.97 ± 0.726.11 ± 0.910.002
Current smoker §8,894 (38.4)8,034 (37.4)860 (51.0)<0.0001589 (50.6)271 (51.9)0.62

Values are n (%) or the mean ± standard deviation.

Participants whose HbA1c values were measured: total (n = 21,995), non-diabetes (n = 20,270), diabetes (n = 1,725), untreated diabetes (n = 1,193), and treated diabetes (n = 532).

Participants whose fasting plasma glucose values were measured: total (n = 21,109), non-diabetes (n = 19,456), diabetes (n = 1,653), untreated diabetes (n = 1,147), and treated diabetes (n = 506).

§Participants whose current smoking status was confirmed by a questionnaire: total (n = 23,146), nondiabetes (n = 21,460), diabetes (n = 1,686), untreated diabetes (n = 1,164), and treated diabetes (n = 522).

Non-diabetes vs. diabetes.

#Untreated diabetes vs. treated diabetes.

BP, blood pressure; HbA1c, glycated hemoglobin.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close